X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs LUPIN LTD - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. LUPIN LTD WOCKHARDT LTD./
LUPIN LTD
 
P/E (TTM) x -15.3 20.1 - View Chart
P/BV x 2.5 2.7 92.1% View Chart
Dividend Yield % 1.3 0.9 142.8%  

Financials

 WOCKHARDT LTD.   LUPIN LTD
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-17
LUPIN LTD
Mar-17
WOCKHARDT LTD./
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs1,1291,750 64.5%   
Low Rs6271,384 45.3%   
Sales per share (Unadj.) Rs363.1387.4 93.7%  
Earnings per share (Unadj.) Rs-20.456.6 -36.1%  
Cash flow per share (Unadj.) Rs-7.076.8 -9.1%  
Dividends per share (Unadj.) Rs10.007.50 133.3%  
Dividend yield (eoy) %1.10.5 237.9%  
Book value per share (Unadj.) Rs301.8298.9 101.0%  
Shares outstanding (eoy) m110.55451.58 24.5%   
Bonus/Rights/Conversions ISESOPS-  
Price / Sales ratio x2.44.0 59.8%   
Avg P/E ratio x-42.927.7 -155.2%  
P/CF ratio (eoy) x-125.920.4 -617.3%  
Price / Book Value ratio x2.95.2 55.5%  
Dividend payout %-48.913.2 -369.3%   
Avg Mkt Cap Rs m97,063707,513 13.7%   
No. of employees `0006.816.8 40.3%   
Total wages/salary Rs m9,66528,495 33.9%   
Avg. sales/employee Rs Th5,931.810,418.3 56.9%   
Avg. wages/employee Rs Th1,428.11,697.0 84.2%   
Avg. net profit/employee Rs Th-334.01,523.0 -21.9%   
INCOME DATA
Net Sales Rs m40,146174,943 22.9%  
Other income Rs m1,1431,065 107.3%   
Total revenues Rs m41,289176,008 23.5%   
Gross profit Rs m12844,931 0.3%  
Depreciation Rs m1,4899,122 16.3%   
Interest Rs m2,2531,525 147.7%   
Profit before tax Rs m-2,47235,349 -7.0%   
Minority Interest Rs m0-72 0.0%   
Prior Period Items Rs m083 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-2119,785 -2.2%   
Profit after tax Rs m-2,26025,575 -8.8%  
Gross profit margin %0.325.7 1.2%  
Effective tax rate %8.527.7 30.9%   
Net profit margin %-5.614.6 -38.5%  
BALANCE SHEET DATA
Current assets Rs m46,160119,542 38.6%   
Current liabilities Rs m19,25861,206 31.5%   
Net working cap to sales %67.033.3 201.0%  
Current ratio x2.42.0 122.7%  
Inventory Days Days10176 132.6%  
Debtors Days Days9490 104.7%  
Net fixed assets Rs m40,165131,660 30.5%   
Share capital Rs m553903 61.2%   
"Free" reserves Rs m32,814134,073 24.5%   
Net worth Rs m33,367134,976 24.7%   
Long term debt Rs m31,90356,478 56.5%   
Total assets Rs m89,687266,073 33.7%  
Interest coverage x-0.124.2 -0.4%   
Debt to equity ratio x1.00.4 228.5%  
Sales to assets ratio x0.40.7 68.1%   
Return on assets %010.2 -0.1%  
Return on equity %-6.818.9 -35.8%  
Return on capital %-0.319.3 -1.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,12181,885 11.1%   
Fx outflow Rs m2,13321,506 9.9%   
Net fx Rs m6,98860,378 11.6%   
CASH FLOW
From Operations Rs m-2,69541,148 -6.5%  
From Investments Rs m-6,863-25,287 27.1%  
From Financial Activity Rs m12,5454,332 289.6%  
Net Cashflow Rs m3,01020,193 14.9%  

Share Holding

Indian Promoters % 74.5 46.6 159.9%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 2.3 11.3 20.4%  
FIIs % 7.7 31.9 24.1%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 10.1 152.5%  
Shareholders   67,757 98,259 69.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   PANACEA BIOTECH  DISHMAN PHARMA  FULFORD INDIA  NATCO PHARMA  DIVIS LABORATORIES  

Compare WOCKHARDT LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Marginally Lower; Capital Goods & Realty Stocks Fall(Closing)

Indian share markets witnessed selling pressure in the final hour of trade to finish just below the dotted line. At the closing bell, the BSE Sensex closed lower by 71 points.

Related Views on News

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Feb 20, 2018 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. - ALEMBIC LTD COMPARISON

COMPARE WOCKHARDT LTD. WITH

MARKET STATS